Premium
Molecular insights into insulin action and secretion
Author(s) -
Rhodes C. J.,
White M. F.
Publication year - 2002
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1046/j.1365-2362.32.s3.2.x
Subject(s) - insulin , insulin receptor , beta cell , insulin resistance , endocrinology , biology , irs2 , medicine , secretion , adipose tissue , glucose homeostasis , insulin receptor substrate , effector , receptor , microbiology and biotechnology , biochemistry , islet
Tightly co‐ordinated control of both insulin action and secretion is required in order to maintain glucose homeostasis. Gene knockout experiments have helped to define key signalling molecules that affect insulin action, including insulin and insulin‐like growth factor‐1 (IGF‐1) receptors, insulin receptor substrate (IRS) proteins and various downstream effector proteins. β‐cell function is also a tightly regulated process, with numerous factors (including certain signalling molecules) having an impact on insulin production, insulin secretion and β‐cell mass. While signalling molecules play important roles in insulin action and secretion under normal circumstances, abnormal insulin signalling in muscle, adipose tissue, liver and pancreas leads to insulin resistance and β‐cell dysfunction. In particular, the signalling protein IRS‐2 may have a central role in linking these abnormalities, although other factors are likely to be involved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom